345 related articles for article (PubMed ID: 28430604)
1. Signal-transducing adaptor protein-2 promotes generation of functional long-term memory CD8+ T cells by preventing terminal effector differentiation.
Muraoka D; Seo N; Hayashi T; Hyuga-Amaike C; Okamori K; Tawara I; Harada N; Shiku H
Oncotarget; 2017 May; 8(19):30766-30780. PubMed ID: 28430604
[TBL] [Abstract][Full Text] [Related]
2. IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.
Liu Z; Liu JQ; Talebian F; Wu LC; Li S; Bai XF
Eur J Immunol; 2013 Feb; 43(2):468-79. PubMed ID: 23225163
[TBL] [Abstract][Full Text] [Related]
3. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells.
Cui W; Liu Y; Weinstein JS; Craft J; Kaech SM
Immunity; 2011 Nov; 35(5):792-805. PubMed ID: 22118527
[TBL] [Abstract][Full Text] [Related]
4. Dok-1 and Dok-2 Regulate the Formation of Memory CD8+ T Cells.
Laroche-Lefebvre C; Yousefi M; Daudelin JF; Charpentier T; Tarrab E; Klinck R; Lamarre A; Labrecque N; Stäger S; Duplay P
J Immunol; 2016 Nov; 197(9):3618-3627. PubMed ID: 27664281
[TBL] [Abstract][Full Text] [Related]
5. Linear differentiation of cytotoxic effectors into memory T lymphocytes.
Opferman JT; Ober BT; Ashton-Rickardt PG
Science; 1999 Mar; 283(5408):1745-8. PubMed ID: 10073942
[TBL] [Abstract][Full Text] [Related]
6. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.
Ives ML; Ma CS; Palendira U; Chan A; Bustamante J; Boisson-Dupuis S; Arkwright PD; Engelhard D; Averbuch D; Magdorf K; Roesler J; Peake J; Wong M; Adelstein S; Choo S; Smart JM; French MA; Fulcher DA; Cook MC; Picard C; Durandy A; Tsumura M; Kobayashi M; Uzel G; Casanova JL; Tangye SG; Deenick EK
J Allergy Clin Immunol; 2013 Aug; 132(2):400-11.e9. PubMed ID: 23830147
[TBL] [Abstract][Full Text] [Related]
7. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
8. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
Park JY; Jin DH; Lee CM; Jang MJ; Lee SY; Shin HS; Chung YH; Kim KY; Kim SS; Lee WB; Shin YK; Lee WJ; Park YM; Kim D
J Immunother; 2010 Jun; 33(5):510-22. PubMed ID: 20463596
[TBL] [Abstract][Full Text] [Related]
9. Complex Interplay Between MAZR and Runx3 Regulates the Generation of Cytotoxic T Lymphocyte and Memory T Cells.
Gülich AF; Rica R; Tizian C; Viczenczova C; Khamina K; Faux T; Hainberger D; Penz T; Bosselut R; Bock C; Laiho A; Elo LL; Bergthaler A; Ellmeier W; Sakaguchi S
Front Immunol; 2021; 12():535039. PubMed ID: 33815354
[TBL] [Abstract][Full Text] [Related]
10. In vivo antitumor function of tumor antigen-specific CTLs generated in the presence of OX40 co-stimulation in vitro.
Pham Minh N; Murata S; Kitamura N; Ueki T; Kojima M; Miyake T; Takebayashi K; Kodama H; Mekata E; Tani M
Int J Cancer; 2018 Jun; 142(11):2335-2343. PubMed ID: 29313971
[TBL] [Abstract][Full Text] [Related]
11. IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.
Schneider R; Yaneva T; Beauseigle D; El-Khoury L; Arbour N
Eur J Immunol; 2011 Jan; 41(1):47-59. PubMed ID: 21182076
[TBL] [Abstract][Full Text] [Related]
12. Disparate roles for STAT5 in primary and secondary CTL responses.
Mitchell DM; Williams MA
J Immunol; 2013 Apr; 190(7):3390-8. PubMed ID: 23440411
[TBL] [Abstract][Full Text] [Related]
13. B cell adaptor for PI3-kinase (BCAP) modulates CD8
Singh MD; Ni M; Sullivan JM; Hamerman JA; Campbell DJ
J Exp Med; 2018 Sep; 215(9):2429-2443. PubMed ID: 30093532
[TBL] [Abstract][Full Text] [Related]
14. SHP-1 in T cells limits the production of CD8 effector cells without impacting the formation of long-lived central memory cells.
Fowler CC; Pao LI; Blattman JN; Greenberg PD
J Immunol; 2010 Sep; 185(6):3256-67. PubMed ID: 20696858
[TBL] [Abstract][Full Text] [Related]
15. The Antitumor Effects of Vaccine-Activated CD8
Wu S; Zhu W; Peng Y; Wang L; Hong Y; Huang L; Dong D; Xie J; Merchen T; Kruse E; Guo ZS; Bartlett D; Fu N; He Y
Cancer Immunol Res; 2017 Oct; 5(10):908-919. PubMed ID: 28851693
[TBL] [Abstract][Full Text] [Related]
16. The Notch signaling pathway controls short-lived effector CD8+ T cell differentiation but is dispensable for memory generation.
Mathieu M; Duval F; Daudelin JF; Labrecque N
J Immunol; 2015 Jun; 194(12):5654-62. PubMed ID: 25972473
[TBL] [Abstract][Full Text] [Related]
17. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
18. Discriminating between different pathways of memory CD8+ T cell differentiation.
Ganusov VV
J Immunol; 2007 Oct; 179(8):5006-13. PubMed ID: 17911585
[TBL] [Abstract][Full Text] [Related]
19. The memory of a killer T cell: models of CD8(+) T cell differentiation.
Gerritsen B; Pandit A
Immunol Cell Biol; 2016 Mar; 94(3):236-41. PubMed ID: 26700072
[TBL] [Abstract][Full Text] [Related]
20. Definition of key variables for the induction of optimal NY-ESO-1-specific T cells in HLA transgene mice.
Johannsen A; Genolet R; Legler DF; Luther SA; Luescher IF
J Immunol; 2010 Sep; 185(6):3445-55. PubMed ID: 20733200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
